Wells P S, Holbrook A M, Crowther N R, Hirsh J
McMaster University, Hamilton, Ontario, Canada.
Ann Intern Med. 1994 Nov 1;121(9):676-83. doi: 10.7326/0003-4819-121-9-199411010-00009.
To evaluate the quality of studies about drugs and food interactions with warfarin and their clinical relevance.
MEDLINE and TOXLINE databases from 1966 to October 1993 using the Medical Subject Headings warfarin, drug interactions, and English only.
All articles reporting original data on drug and food interactions with warfarin.
Each report, rated independently by at least two investigators (using causality assessment), received a summary score indicating the level of assurance (level 1 = highly probable, level 2 = probable, level 3 = possible, and level 4 = doubtful) that a clinically important interaction had or had not occurred. Inter-rater agreement was assessed using a weighted kappa statistic.
Of 793 retrieved citations, 120 contained original reports on 186 interactions. The weighted kappa statistic was 0.67, representing substantial agreement. Of 86 different drugs and foods appraised, 43 had level 1 evidence. Of these, 26 drugs and foods did interact with warfarin. Warfarin's anticoagulant effect was potentiated by 6 antibiotics (cotrimoxazole, erythromycin, fluconazole, isoniazid, metronidazole, and miconazole); 5 cardiac drugs (amiodarone, clofibrate, propafenone, propranolol, and sulfinpyrazone); phenylbutazone; piroxicam; alcohol (only with concomitant liver disease); cimetidine; and omeprazole. Three patients had a hemorrhage at the time of a potentiating interaction (caused by alcohol, isoniazid, and phenylbutazone). Warfarin's anticoagulant effect was inhibited by 3 antibiotics (griseofulvin, rifampin, and nafcillin); 3 drugs active on the central nervous system (barbiturates, carbamazepine, and chlordiazepoxide); cholestyramine; sucralfate; foods high in vitamin K; and large amounts of avocado.
Many drugs and foods interact with warfarin, including antibiotics, drugs affecting the central nervous system, and cardiac medications. Many of these drug interactions increase warfarin's anticoagulant effect.
评估关于药物及食物与华法林相互作用的研究质量及其临床相关性。
1966年至1993年10月期间的MEDLINE和TOXLINE数据库,使用医学主题词“华法林”“药物相互作用”,且仅检索英文文献。
所有报告药物及食物与华法林相互作用原始数据的文章。
每份报告由至少两名研究人员独立评估(采用因果关系评估),获得一个总结分数,表明临床上重要的相互作用是否发生的确定程度(1级 = 极有可能,2级 = 有可能,3级 = 可能,4级 = 可疑)。使用加权kappa统计量评估评分者间的一致性。
在检索到的793篇文献中,120篇包含186种相互作用的原始报告。加权kappa统计量为0.67,表示有实质性的一致性。在评估的86种不同药物和食物中,43种有1级证据。其中,26种药物和食物确实与华法林发生相互作用。6种抗生素(复方新诺明、红霉素、氟康唑、异烟肼、甲硝唑和咪康唑)、5种心脏药物(胺碘酮、氯贝丁酯、普罗帕酮、普萘洛尔和磺吡酮)、保泰松、吡罗昔康、酒精(仅在伴有肝病时)、西咪替丁和奥美拉唑增强了华法林的抗凝作用。3名患者在增强相互作用时发生出血(由酒精、异烟肼和保泰松引起)。3种抗生素(灰黄霉素、利福平、萘夫西林)、3种作用于中枢神经系统的药物(巴比妥类、卡马西平和氯氮卓)以及考来烯胺、硫糖铝、富含维生素K的食物和大量鳄梨抑制了华法林的抗凝作用。
许多药物和食物与华法林相互作用,包括抗生素、影响中枢神经系统的药物和心脏药物。这些药物相互作用中有许多增强了华法林的抗凝作用。